Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future
Inflammatory bowel disease (IBD) is a group of heterogeneous chronic inflammatory diseases of the gut presenting with intestinal and extraintestinal manifestations. Most cases fit in predominantly two types, namely, ulcerative colitis and Crohn's disease. The incidence of IBD has been increasin...
Saved in:
Main Authors: | Manish Manrai (Author), Atul Abhishek Jha (Author), Saurabh Dawra (Author), Aditya Vikram Pachisia (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual biological therapy and small molecules in pediatric inflammatory bowel disease
by: Francesca Penagini, et al.
Published: (2023) -
Small Molecule Drugs in Inflammatory Bowel Diseases
by: Inès Ben Ghezala, et al.
Published: (2021) -
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017) -
Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
by: Rawla P, et al.
Published: (2018) -
Non-neoplastic disorders in an aging gut: concise review
by: Saurabh Dawra, et al.
Published: (2023)